Download PDF
Rofo 2019; 191(01): 40-47
DOI: 10.1055/a-0638-0058
Chest
© Georg Thieme Verlag KG Stuttgart · New York

Selecting Patients for Lobar Lung Volume Reduction Therapy: What Quantitative Computed Tomography Parameters Matter?

Selektionskriterien für die Lungenvolumenreduktionstherapie: Welche Parameter der quantitativen Computertomografie sind relevant?
Dorothea Cornelia Theilig
1   Department of Radiology, Charité Universitätsmedizin Berlin, Germany
,
Ralf-Harto Huebner
2   Department of Internal Medicine / Infectious and respiratory Disease, Charité Universitätsmedizin Berlin, Germany
,
Konrad Neumann
3   Institute of Biometrics and Clinical Epidemiology, Charité Universitätsmedizin Berlin, Germany
,
Alexander Poellinger
4   Department of Radiology, Inselspital, University of Bern, Switzerland
,
Felix Doellinger
1   Department of Radiology, Charité Universitätsmedizin Berlin, Germany
› Author Affiliations
Further Information

Publication History

06 February 2018

24 May 2018

Publication Date:
11 October 2018 (online)

Also available at
   Permissions and Reprints

Abstract

Purpose Evaluation of emphysema distribution with quantitative computed tomography (qCT) prior to endoscopic lung volume reduction (ELVR) is recommended. The aim of this study was to determine which of the commonly assessed qCT parameters prior to endoscopic lung volume reduction (ELVR) best predicts outcome of treatment.

Materials and Methods 50 patients who underwent technically successful ELVR at our institution were retrospectively analyzed. We performed quantitative analysis of the CT scans obtained prior to ELVR and carried out Mann-Whitney U-tests and a logistic regression analysis to identify the qCT parameters that predict successful outcome of ELVR in terms of improved forced expiratory volume in 1 second (FEV1).

Results In the Mann-Whitney U-test, the interlobar emphysema heterogeneity index (p = 0.008) and the pulmonary emphysema score (p = 0.022) showed a statistically significant difference between responders and non-responders. In multiple logistic regression analysis only the interlobar emphysema heterogeneity index (p = 0.008) showed a statistically significant impact on the outcome of ELVR, while targeted lobe volume, total lung volume, targeted lobe emphysema score and total lung emphysema score did not.

Conclusion Of all commonly assessed quantitative CT parameters, only the heterogeneity index definitely allows prediction of ELVR outcome in patients with advanced chronic obstructive pulmonary disease (COPD).

Key Points 

  • Quantitative CT is recommended prior to ELVR.

  • The relevance of the obtained parameters from quantitative CT remains controversial.

  • This study confirms that only the emphysema heterogeneity index has a definite impact.

Citation Format

  • Theilig DC, Huebner R, Neumann K et al. Selecting Patients for Lobar Lung Volume Reduction Therapy: What Quantitative Computed Tomography Parameters Matter?. Fortschr Röntgenstr 2019; 191: 40 – 47

Zusammenfassung

Ziel Vor endoskopischer Lungenvolumenreduktion (ELVR) ist die Evaluation der Emphysemverteilung mittels quantitativer Computertomografie (qCT) empfohlen. Ziel dieser retrospektiven Studie war festzustellen, welche qCT-Parameter das postinterventionelle Outcome am besten vorhersagen.

Material und Methoden Die präinterventionellen Computertomografien von fünfzig in unserer Institution technisch erfolgreich mit ELVR behandelten Patienten wurden quantitativ analysiert und mit prä- und postinterventionellen Lungenfunktionsuntersuchungen verglichen. Untersucht wurde die Relevanz der standardmäßig erhobenen qCT-Parameter, d. h. Gesamtlungenvolumen, Ziellappenvolumen, Emphysemindex der gesamten Lunge und des Ziellappens sowie Heterogenitätsindex. Mann-Whitney U-Test und logistische Regressionsanalyse wurden zur Identifikation derjenigen Parameter verwendet, die am besten einen Anstieg der FEV1 hervorsagten.

Ergebnisse Im Mann-Whitney U-Test unterschieden sich lediglich interlobärer Emphysemheterogenitätsindex (p = 0,008) und pulmonaler Emphysemindex (p = 0,022) signifikant zwischen Therapieansprechern und Therapieversagern. Die logistische Regressionsanalyse zeigte lediglich für den Heterogenitätsindex signifikante Unterschiede zwischen beiden Patientengruppen (p = 0,008). Gesamtlungenvolumen, Ziellappenvolumen, sowie die Emphysemindices der gesamten Lunge und des Ziellappens wiesen dort keine signifikanten Unterschiede auf.

Schlußfolgerungen Von allen bei der präinterventionellen qCT erhobenen Parametern scheint lediglich der interlobäre Heterogenitätsindex das klinische Outcome nach ELVR verlässlich vorauszusagen.

Kernaussagen 

  • Vor ELVR wird die Durchführung einer quantitativen CT empfohlen.

  • Die Relevanz der qCT-Parameter ist weiterhin umstritten.

  • Diese Studie bekräftigt, dass ausschließlich die Emphysemheterogenität einen relevanten Einfluss hat.

Key words

CT-quantitative - chronic obstructive pulmonary disease - lung volume reduction therapy
 

  • References

  • 1 Sciurba FC, Ernst A, Herth FJ. et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363: 1233-1244 . doi:10.1056/NEJMoa0900928
    CrossrefPubMedGoogle Scholar
  • 2 Klooster K, ten Hacken NH, Hartman JE. et al. Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation. N Engl J Med 2015; 373: 2325-2335 . doi:10.1056/NEJMoa1507807
    CrossrefPubMedGoogle Scholar
  • 3 Davey C, Zoumot C, Jordan S. et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet 2015; 386: 1066-1073 . doi:10.1016/S0140-6736(15)60001-0
    CrossrefPubMedGoogle Scholar
  • 4 Park TS, Hong Y, Lee JS. et al. Efficacy of bronchoscopic lung volume reduction by endobronchial valves in patients with heterogeneous emphysema: report on the first Asian cases. Journal of Korean medical science 2014; 29: 1404-1410 . doi:10.3346/jkms.2014.29.10.1404
    CrossrefPubMedGoogle Scholar
  • 5 Park TS, Hong Y, Lee JS. et al. Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: the first Asian report. International journal of chronic obstructive pulmonary disease 2015; 10: 1501-1511 . doi:10.2147/COPD.S85744
    PubMedGoogle Scholar
  • 6 Koegelenberg CF, Theron J, Bruwer JV. et al. Endoscopic lung volume reduction in severe emphysema. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2015; 105: 721-723 . doi:10.7196/SAMJnew.8144
    PubMedGoogle Scholar
  • 7 Valipour A, Burghuber OC. An update on the efficacy of endobronchial valve therapy in the management of hyperinflation in patients with chronic obstructive pulmonary disease. Therapeutic advances in respiratory disease 2015; 9: 294-301 . doi:10.1177/1753465815599693
    CrossrefPubMedGoogle Scholar
  • 8 Herth FJ, Noppen M, Valipour A. et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39: 1334-1342
    CrossrefPubMedGoogle Scholar
  • 9 Gompelmann D, Sarmand N, Herth FJ. Interventional pulmonology in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2017; DOI: 10.1097/MCP.0000000000000373.
    CrossrefPubMedGoogle Scholar
  • 10 Cetti EJ, Moore AJ, Geddes DM. Collateral ventilation. Thorax 2006; 61: 371-373 . doi:10.1136/thx.2006.060509
    CrossrefPubMedGoogle Scholar
  • 11 Herth FJ, Eberhardt R, Gompelmann D. et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J 2013; 41: 302-308 . doi:10.1183/09031936.00015312
    PubMedGoogle Scholar
  • 12 Gompelmann D, Eberhardt R, Slebos DJ. et al. Diagnostic performance comparison of the Chartis System and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. Respirology 2014; 19: 524-530 . doi:10.1111/resp.12253
    CrossrefPubMedGoogle Scholar
  • 13 Gompelmann D, Eberhardt R, Schuhmann M. et al. Lung Volume Reduction with Vapor Ablation in the Presence of Incomplete Fissures: 12-Month Results from the STEP-UP Randomized Controlled Study. Respiration international review of thoracic diseases 2016; 92: 397-403 . doi:10.1159/000452424
    PubMedGoogle Scholar
  • 14 Shah PL, Herth FJ. Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax 2014; 69: 280-286 . doi:10.1136/thoraxjnl-2013-203743
    CrossrefPubMedGoogle Scholar
  • 15 Wan IY, Toma TP, Geddes DM. et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest 2006; 129: 518-526 . doi:10.1378/chest.129.3.518
    CrossrefPubMedGoogle Scholar
  • 16 Fiorelli A, Petrillo M, Vicidomini G. et al. Quantitative assessment of emphysematous parenchyma using multidetector-row computed tomography in patients scheduled for endobronchial treatment with one-way valvesdagger. Interactive cardiovascular and thoracic surgery 2014; 19: 246-255 . doi:10.1093/icvts/ivu107
    CrossrefPubMedGoogle Scholar
  • 17 Jones PW, Beeh KM, Chapman KR. et al. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med 2014; 189: 250-255 . doi:10.1164/rccm.201310-1863PP
    CrossrefPubMedGoogle Scholar
  • 18 Thomsen C, Theilig D, Herzog D. et al. Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy. International journal of chronic obstructive pulmonary disease 2016; 11: 1245-1259 . doi:10.2147/COPD.S101003
    PubMedGoogle Scholar
  • 19 Kuhnigk JM, Dicken V, Zidowitz S. et al. Informatics in radiology (infoRAD): new tools for computer assistance in thoracic CT. Part 1. Functional analysis of lungs, lung lobes, and bronchopulmonary segments. Radiographics 2005; 25: 525-536 . doi:25/2/525 [pii] 1148/rg.252045070
    CrossrefPubMedGoogle Scholar
  • 20 Matsuo K, Iwano S, Okada T. et al. 3D-CT lung volumetry using multidetector row computed tomography: pulmonary function of each anatomic lobe. Journal of thoracic imaging 2012; 27: 164-170 . doi:10.1097/RTI.0b013e31822641c9
    CrossrefPubMedGoogle Scholar
  • 21 Gevenois PA, De Vuyst P, de Maertelaer V. et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996; 154: 187-192 . doi:10.1164/ajrccm.154.1.8680679
    CrossrefPubMedGoogle Scholar
  • 22 Wang Z, Gu S, Leader JK. et al. Optimal threshold in CT quantification of emphysema. European radiology 2013; 23: 975-984 . doi:10.1007/s00330-012-2683-z
    CrossrefPubMedGoogle Scholar
  • 23 Lynch DA, Al-Qaisi MA. Quantitative computed tomography in chronic obstructive pulmonary disease. Journal of thoracic imaging 2013; 28: 284-290 . doi:10.1097/RTI.0b013e318298733c
    CrossrefPubMedGoogle Scholar
  • 24 Theilig D DF, Poellinger A, Schreiter V. et al. Camparison of distinctive models for calculating an interlobar emphysema heterogeneity index in patients prior to endoscopic lung volume reduction. International Journal of COPD 2017; 2017:12: 1631-1640
    PubMedGoogle Scholar
  • 25 Gompelmann D, Hofbauer T, Gerovasili V. et al. Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy: A retrospective study. Respirology 2016; 21: 1255-1261 . doi:10.1111/resp.12819
    CrossrefPubMedGoogle Scholar
  • 26 National Emphysema Treatment Trial Research. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001; 345: 1075-1083 . doi:10.1056/NEJMoa11798
    CrossrefPubMedGoogle Scholar
  • 27 Koster TD, van Rikxoort EM, Huebner RH. et al. Predicting Lung Volume Reduction after Endobronchial Valve Therapy Is Maximized Using a Combination of Diagnostic Tools. Respiration international review of thoracic diseases 2016; 92: 150-157 . doi:10.1159/000448849
    PubMedGoogle Scholar
  • 28 van Rikxoort EM, Goldin JG, Galperin-Aizenberg M. et al. A method for the automatic quantification of the completeness of pulmonary fissures: evaluation in a database of subjects with severe emphysema. European radiology 2012; 22: 302-309 . doi:10.1007/s00330-011-2278-0
    CrossrefPubMedGoogle Scholar
  • 29 Vestbo J, Hurd SS, Agusti AG. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365 . doi:10.1164/rccm.201204-0596PP
    CrossrefPubMedGoogle Scholar
  • 30 CPMP. Points to consider on clinical investigation od medicinal products in the chronic treatment of patients with chronic obstructive pulmonary disease (COPD). The European Agency for the Evaluation of Medical Products 1999. London. CPMP/EWP/562/598
    PubMedGoogle Scholar